Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
10162781 | Journal of Pharmaceutical Sciences | 2012 | 18 Pages |
Abstract
Controlling aggregation in protein therapeutics is a significant challenge. In this study, the aggregation behavior of albinterferon-α2b, a genetic fusion protein combining human serum albumin and α-interferon, was examined as a function of solution conditions. The stability was monitored during agitation and during storage at elevated temperature, where the extent of aggregation was determined using size-exclusion chromatography. The osmotic second virial coefficient and the free energy of unfolding were measured for each sample. This study demonstrates that both increasing conformational stability and maximizing colloidal stability help to maintain the physical stability of albinterferon-α2b. © 2012 Wiley Periodicals, Inc. and the American Pharmacists Association
Keywords
Related Topics
Health Sciences
Pharmacology, Toxicology and Pharmaceutical Science
Drug Discovery
Authors
Danny K. Chou, Rajesh Krishnamurthy, Mark Cornell Manning, Theodore W. Randolph, John F. Carpenter,